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Abstract
Background: Dnmt3a is a DNA methyltransferase that establishes de novo DNA methylation in mammals. The
structure of the Dnmt3a C-terminal domain is similar to the bacterial M. HhaI enzyme, a well-studied prokaryotic
DNA methyltransferase. No X-ray structure is available for the complex of Dnmt3a with DNA and the mechanistic
details of DNA recognition and catalysis by mammalian Dnmts are not completely understood.
Results: Mutant variants of the catalytic domain of the murine Dnmt3a carrying substitutions of highly conserved
N167, R200, and R202 have been generated by site directed mutagenesis and purified. Their methylation activity,
DNA binding affinity, ability to flip the target cytosine out of the DNA double helix and covalent complex formation
with DNA have been examined. Substitutions of N167 lead to reduced catalytic activity and reduced base flipping.
Catalytic activity, base flipping, and covalent conjugate formation were almost completely abolished for the mutant
enzymes with substitutions of R200 or R202.
Conclusions: We conclude that R202 plays a similar role in catalysis in Dnmt3a-CD as R232 in M.SssI and R165 in
M.HhaI, which could be positioning of the cytosine for nucleophilic attack by a conserved Cys. R200 of Dnmt3a-CD
is important in both catalysis and cytosine flipping. Both conserved R200 and R202 are involved in creating and
stabilizing of the transient covalent intermediate of the methylation reaction. N167 might contribute to the
positioning of the residues from the motif VI, but does not play a direct role in catalysis.
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Background
DNA methylation is a key epigenetic modification in
eukaryotes that is essential for various developmental
processes, including regulation of gene expression and
cell differentiation, genomic imprinting, X-chromosome
inactivation, and epigenetic inheritance [1–4]. In mam-
mals, DNA methylation is mediated and maintained by
DNA methyltransferases (MTases). These enzymes trans-
fer the methyl group from the cofactor S-adenosyl-L-me-
thionine (AdoMet) to the 5-position of cytosine mainly
within CpG dinucleotides [5, 6]. Mammalian genomic
DNA methylation is established de novo by DNA methyl-
transferases Dnmt3a and Dnmt3b [6–8]. Pre-existing
DNA methylation patterns are primarily maintained by
Dnmt1 [8]. However, the roles of the Dnmts are also over-
lapping, and Dnmt1 contributes to de novo methylation
as well as Dnmt3 enzymes are needed for the long term
maintainance of DNA methylation [9]. Dnmt3-like protein
(Dnmt3L) is a paralogue of the Dnmt3 enzymes that lacks
catalytic activity and functions as regulatory protein of the
Dnmt3 enzymes [10].
Defects in genes of the dnmt family lead to various
developmental defects and cancers [2, 11]. Recent
cancer genome sequencing revealed dnmt3a as one of
the most frequently mutated genes across a range of
haematological malignancies [12]. These findings
emphasize the importance of DNA methylation not
only in embryonic development, but also in the main-
tenance of normal physiology.
Mammalian MTases consist of an N-terminal part,
which serves regulatory and targeting functions, and
a C-terminal catalytic domain, which contains 10
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characteristic amino acid motifs that are conserved among
all cytosine-C5 MTases [13, 14]. Unlike Dnmt1, the iso-
lated C-terminal domains of Dnmt3a and Dnmt3b are
catalytically active [15]. The C-terminal domains of
Dnmt3a and Dnmt3L form a tetrameric complex with
two active sites that are separated by about one DNA
helical turn [16]. Recent structural studies of Dnmt3a–
Dnmt3L-histone H3 complexes revealed that Dnmt3a ex-
ists in an autoinhibitory form, where the ADD domain of
Dnmt3a interacts with and inhibits the enzymatic activ-
ity of the catalytic domain [17]. Histone H3 disrupts
this interaction, and thus releases the autoinhibition of
Dnmt3a.
Bacterial C5-MTases perform the methylation reaction
according to a common mechanism that involves DNA
recognition and binding, target cytosine flipping out of
the double helix, attack of the conserved cysteine at C6
position and covalent intermediate formation, followed
by methyl group transfer from the donor AdoMet, reso-
lution of the intermediate and release of the products
[6, 18]. The structure of the Dnmt3a C-terminal do-
main is similar to the bacterial M. HhaI enzyme, a
well-studied prokaryotic MTase [16]. In the Dnmt3a-
Dnmt3L structure docked to a DNA molecule with a
flipped target cytosine (Cyt), the target Cyt is located
between the nucleophile C706 and AdoMet, as in
M.HhaI [19, 20]. Both Dnmt3a and Dnmt1 are able
to form transient covalent intermediates with DNA
containing MTase-trapping base 2-pyrimidinone [21, 22].
Taken together, these observations support the evidence
that the same mechanism of C5-methylation is oper-
ational in mammalian and bacterial MTases.
Although a few structures of Dnmt3a and its individ-
ual domains have been published to date, there are no
known structures for the Dnmt3a bound to DNA. Much
progress has been made in recent years in our under-
standing of how MTases function and what the roles are
for key amino acid residues in the catalytic process. Mu-
tational analysis of two CpG MTases provided an insight
into their catalytic mechanism. The computational
model of the prokaryotic CpG MTase M.SssI and its
mutational analysis confirmed previously suggested roles
for amino acid residues involved in DNA base flipping
(S145, R232, T313) and catalysis (E286), and identified a
new essential catalytic residue (R230) [23]. Initial muta-
tional analysis of 14 amino acid residues located within
ten conserved amino acid sequence motifs has been per-
formed on Dnmt3a-CD in the absence of structure for
Dnmt3a-DNA complex [24].
This work is a continuation of the Dnmt3a mutational
analysis. We examined in detail the role of N167 (Fig. 1a)
of Dnmt3a-CD (motif IV) that might be involved in po-
sitioning of the residues from motif VI [24] (the corre-
sponding numbers of the amino acids in full length
Dnmt3a are indicated in Table 2). R200 and R202 of
Dnmt3a-CD (motif VIII, Fig. 1a) were selected on the
basis of our computational model of the ternary
M.SssI•DNA•AdoHcy complex and results of mutational
analyses of Dnmt3a-CD, M.SssI and M.HhaI MTases
[23–25]. The mutated amino acid residues are shown on
the model of Dntm3a/DNA complex (Fig. 1b). These
residues may play a role in catalysis of cytosine-C5
methyltransferases. Mutant forms of Dnmt3a-CD were
generated by site-directed mutagenesis and key steps of
the methylation reaction were studied biochemically.
Methods
Chemicals, oligodeoxynucleotides and enzymes
[CH3-
3H]AdoMet (15 Ci/mmol, 66.7 μM) was purchased
from Amersham Biosciences (Little Chalf-ont, U.K.).
AdoHcy was from Sigma (St. Louis, MO). All unmodified
or 2-aminopurine-containing oligodeoxynucleotides were
purchased from Syntol (Moscow, Russsia). The oligodeox-
ynucleotide containing 2-pyrimidinone was synthesized by
S.N. Mikhailov (Moscow, Russia), and its composition was
confirmed by mass spectrometry using a Bruker Daltonics
Reflex II MALDITOF MS instrument (Bruker, Billerica,
MA). The fluorescent label (FAM) was 5′-linked to oligo-
nucleotides by a hexamethylene linker. Oligodeoxynucleo-
tide sequences are presented in Table 1.
Oligodeoxynucleotide duplexes were prepared by an-
nealing the complementary strands in 10 mM Tris–HCl
(pH 7.9) buffer containing 50 mM NaCl.
Plasmids and mutant enzymes
Expression constructs of Dnmt3a-CD and Dnmt3L have been
described previously [16, 24]. Selected amino acids of CD-
Dnmt3a were mutated using a PCR-megaprimer mutagenesis
method as described [24]. Mutagenesis was confirmed by
Sanger sequencing. Dnmt3a-CD and Dnmt3L were overex-
pressed in BL21(DE3) E.coli as N-terminally His6-tagged or
His8-tagged proteins, respectively, and purified according to
the previously described protocol [26]. Mutant forms of
Dnmt3a-CD were isolated and purified in the same way as
the wild type (wt)-enzyme. The concentrations of protein
samples were measured by standard Bradford technique.
DNA methylation
DNA methylation was monitored by the time depend-
encies of amount of tritium-labeled methyl groups
transferred from [CH3-
3H]AdoMet to cytosine by the
enzymes as described [26]. The reaction mixtures con-
tained 1.5 μM GCGC/CGCG, 2 μM [CH3-
3H]AdoMet
and 0.89 μM Dnmt3a-CD or its mutant form in
Dnmt3a reaction buffer (10 mM Tris–HCl, pH 7.9,
50 mM NaCl, 2 mM mercaptoethanol). Aliquots of
the reaction mixtures were pipetted onto DE-81 paper
disks (Whatman) after 10–40 min intervals. Amount
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of incorporated radioactivity was counted and plotted
using Origin 6.0 software (OriginLab).
DNA binding
DNA binding was monitored by fluorescence polarization.
Fluorescence polarization (P) was measured at 25 °C in
quartz cuvette «Hellma» with a 1-cm pathlength using a
Cary Eclipse (Varian) spectrofluorimeter, with excitation
at 495 nm and emission at 520 nm, and slit widths were
10 nm. 10 nM fGCGC/CGCG was preincubated with
0.1 mM AdoHcy in Dnmt3a reaction buffer, and fluores-
cence polarization of free DNA (P0) was measured. Then
Fig. 1 The amino acid residues subjected to mutational analysis. a Multiple sequence alignment of mammalian Dnmt3a (from mouse and human),
Dnmt3b and Dnmt1 with prokaryotic M.SssI, M.HpaI and M.HhaI. Sequences were aligned by ClustalW algorithm and shaded using BoxShade server.
b Model of Dnmt3a-CD (green) with short DNA molecule (blue) adopted by superposition of the M.HhaI-DNA complex structure [20] onto Dnmt3a-CD/
Dnmt3L tetramer structure [16]. Top (top panel) and side (bottom panel) views. The motifs IV (PCN), VI (ENV) and VIII (QxRxR) are shown
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Dnmt3a-CD or its mutant variant was added as 1–
5 μL aliquots of the stock solution (2.91 μM) up to a
final concentration of 600–800 nM, and the
polarization value (P) recorded at 1 min after each
addition was measured. Titration curves were analyzed
using SCIENTIST software from MacroMath (St.Louis,
MO). Dissociation constants, Kd1 and Kd2 and the product
Kd1Kd2 were obtained from the model of cooperative bind-
ing as described in [27].
Base flipping
Base flipping was studied by fluorescence spectros-
copy as described in [23]. Dnmt3a-CD (300 nM) or
its mutant was incubated with Dnmt3L (300 nM) at
37 °C in Dnmt3a reaction buffer containing 0.1 mM
AdoMet and 200 nM 2-aminopurine-containing duplex
GBGC/CGMG. The spectra were recorded 10 min follow-
ing incubation. Background correction was implemented
by subtraction of the control spectrum obtained with
a reaction mixture containing GCGC/CGMG instead
of 2-aminopurine substituted DNA. The fluorescence
enhancement was calculated for the individual mutant
relative to the wt enzyme.
Detection of MTase-DNA conjugates
Reactions contained 200 nM FAM-labeled duplex
fCG/GP, 0.1 mM AdoHcy and 2 μM Dnmt3a-CD (wt
or mutant) in Dnmt3a reaction buffer. After incubation at
4 °C for 60 min the samples were incubated with 1 % SDS
at room temperature for 10 min. Samples were subjected
to electrophoresis in 12.5 % denaturing Laemmli poly-
acrylamide gels containing 0.1 % SDS. The gels were ana-
lyzed by fluorography using FUJIFILM FLA-3000 (Japan).
Results
Amino acid exchanges of the conserved residues N167,
R200 and R202 of the murine Dnmt3a-CD (Fig. 1) were
introduced by site-directed mutagenesis. The Dnmt3a-
CD mutants were expressed in E.coli as C-terminal His6-
proteins and purified in soluble form (Fig. 2).
DNA methylation activity
DNA methylation activity of the purified enzymes was
quantitatively assessed by calculating the initial rate of
methylation (v0). Time dependencies were determined
for the incorporation of radioactive labeled methyl
groups from S-[methyl-3H]-AdoMet to unmethylated
30-mer DNA duplex GCGC/CGCG, which harbors one
centrally placed CG site (in bold, methylated cytosine is
underlined) by the wild type (wt) Dnmt3a-CD or its mu-
tants. The reactions were carried out under conditions
where the DNA concentration was 1.7-fold greater than
that of the enzyme. Dnmt3a-Dnmt3L heterodimers
might have higher intrinsic activity than Dnmt3a-
Dnmt3a homooligomers, in part because Dnmt3L favors
the catalytically competent closed conformation of the
Dnmt3a active-site loop [16, 19]. However, functional
analysis of mutants can be performed in the absence of
Dnmt3L since Dnmt3a-CD oligomers are catalytically
active enough to achieve significant signal in the methy-
lation assay. The time courses for all mutants were lin-
ear, as it is exemplified for the N167A mutant (Fig. 3a).
The obtained relative methylation rates are presented in
Fig. 3b and Table 2. The Ala, Glu and Lys substitutions
for R200 led to an almost complete loss of methylation
activity. This result suggests that R200 is extremely im-
portant for Dnmt3a-CD functioning. The N167A and
R202A also displayed significantly reduced DNA methy-
lation rates (6- and 8-fold, respectively) that is in accord-
ance with previous findings [24].
DNA binding affinity
Binding to DNA is the first step of the methylation
reaction. Changes in the methylation rates of mutant
Fig. 2 Coomassie blue-stained SDS-polyacrylamide gel showing the
purified recombinant Dnmt3a-CD protein, its variants and Dnmt-3 L









aM, 5-methylcytosine; В, 2-aminopurine; P, 2-pyrimidinone; FAM
(f), 6-carboxyfluorescein
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enzymes may result from their altered substrate
binding affinities. Complex formation was monitored
by changes in fluorescence polarization using a FAM-
labeled oligodeoxynucleotide duplex fGCGC/CGCG
binding substrate. Binding measurements were per-
formed in the presence of the cofactor product,
AdoHcy. Binding curves displayed cooperative bind-
ing (Fig. 4). The data were analyzed according to the
previously published model that includes binding of
two Dnmt3a-CD complexes to 30-mer DNA duplexes
to form a catalytically more competent multimeric
complex [26, 27]. In this model, individual binding
constants for binding of the first Dnmt3a complex
(Kd1) and the second Dnmt3a complex (Kd2) were
obtained. The product Kd1Kd2 was used as a binding
characteristic for the mutant enzymes (Table 2). All
R200 substitutions did not lead to a loss of binding
cooperativity. Replacement of R200 to Ala or Lys did
Fig. 3 Time courses of methylation of oligodeoxynucleotide duplex by wt or Dnmt3a-CD variants. a The reaction mixtures contained
1.5 μM GCGC/CGCG, 0.89 μM Dnmt3a-CD or its variants, and 2 μM [CH3-3H]AdoMet. b Relative initial methylation rates (v0rel,%) for wt
and Dnmt3a-CD variants. The error bars represent the SDs derived from at least three independent experiments
Table 2 Methylation activity, DNA binding affinity, and 2-aminopurine base flipping by Dnmt3a-CD mutantsa
Exchange Corresponding residue
in full length Dnmt3a




rel, % Relative intensity of 2-aminopurine
fluorescence, at 370 nm, %
wt 73 ± 17 14 ± 5 1022 1.00 0.83 ± 0.09 100 100
N167A N753 n.d. n.d. n.d. 0.7b 0.14 ± 0.02 17 29.4
R200A R786 79 ± 17 14 ± 6 1106 0.92 <0.020 2 3.9
R200E R786 159 ± 37 33 ± 12 5247 0.19 <0.022 3 5.3
R200K R786 55 ± 14 9 ± 3 495 2.06 <0.035 4 15.4
R202A R788 n.d. n.d. n.d. 1.20b <0.100 12 0.9
aThe amino acid numbers in Dnmt3a catalytic domain are given relative to the murine full-length Dnmt3a (NCBI reference sequence NP_001258682.1). n.d. desig-
nates not determined
The given values are representative of two or more experiments
bData from ref. [24]
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not affect DNA binding significantly. However, there
was a 5-fold decrease in Kd1Kd2 for the R200E vari-
ant. This indicates that R200 does not play crucial
role in DNA binding, but the reversal in polarity of
this residue led to the deterioration of binding
because of possible repulsion of negative charges of
glutamate and DNA phosphate backbone. As it was
shown previously, the N167A variant displayed
slightly decreased binding affinity, whereas binding of
R202A to DNA was not affected (Table 2 and [24]).
Defects in methylation activity for N167A and R202A
(Table 2) cannot be explained by their slightly re-
duced DNA binding, therefore, it was necessary to
investigate next steps of the methylation reaction.
Base flipping
Flipping of the target cytosine by Dnmt3a-CD and its
mutants in the presence of Dnmt3L was analyzed
using hemimethylated oligonucleotide duplex GBGC/
CGMG containing the fluorescent base 2-aminopurine
in place of the target cytosine. The fluorescence of 2-
aminopurine is highly quenched in the helix due to
stacking interactions with neighboring bases, and in-
creases strongly when the base is flipped out [28, 29].
Dnmt3a-CD alone, when mixed with 2-aminopurine
containing DNA, produced low signal with high signal
to noise ratio (data not shown). To increase the en-
zymatic activity of the complex, Dnmt3L was added.
The changes in the 2-aminopurine fluorescence upon
mixing of the substrate with enzymes are given in
Table 2, examples of the emission fluorescence spec-
tra are shown in Fig. 5. The complex of wt Dnmt3a-
CD-Dnmt3L with duplex GBGC/CGMG gave a strong
fluorescence signal with a characteristic maximum at
365–370 nm in the presence of the cofactor AdoMet
(Fig. 5). The fluorescence signal observed for N167A
mutant was 3.5-fold lower than that for the wt-enzyme.
R200K mutant, despite its elevated binding affinity
(Table 2), showed 7-fold reduction in the fluorescence sig-
nal. Other mutants (R200A, R200E, R200A and R202A)
produced much lower signal (Table 2 and Fig. 5), which is
consistent with the loss of base flipping.
Covalent intermediate formation
One of the key steps of the DNA methylation reac-
tion is the formation of the transient covalent com-
plex between the enzyme and its substrate DNA. This
step was studied for wt Dnmt3a and its mutant vari-
ants using an oligonucleotide duplex fCG/GP contain-
ing 2-pyrimidinone at the place of the target cytosine
and terminal fluorescent label for fluorographic detec-
tion. Normally, the nucleophylic attack of the highly
conserved cysteine of the motif IV at the C6 position
of the cytosine ring produces the covalent conjugate,
which triggers the subsequent methyl group transfer
from AdoMet to the C5 carbon atom. The covalent
complex is resolved by deprotonation at C5 leading
to ß-elimination of the cysteine residue [18]. Conjugates
of C5-MTases with DNA containing 2-pyrimidinone
instead of the target cytosine are stable due to the re-
tardation of β-elimination and can be detected by gel
electrophoresis [23, 30].
The wt Dnmt3a-CD forms SDS-resistant complexes in
the presence of AdoHcy (Fig. 6). Covalent intermediate
was detected with the N167A mutant enzyme as well, al-
though with slightly reduced efficiency, which reflects its
Fig. 4 Binding curves obtained by titration of the fluorescein labeled unmethylated oligodeoxynucleotide duplex fGCGC/CGCG (10 nM)
with increasing amounts of Dnmt3a-CD or its variants in the presence of AdoHcy (0.1 mM). P represents the polarization value. The lines
signify the best fits to the model described in [27]. Enzyme concentration is shown in terms of monomer
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reduced binding affinity (Table 2). No covalent complex
was produced in the case of mutant enzymes carrying
substitutions of R200 and R202. This fact, together with
the abolished base flipping (Fig. 5) demonstrates the out-
standing importance of these two Arg residues in the en-
zyme functioning.
Discussion
The methylation reaction of the C5-MTases is thought
to consist of the following steps [6, 15, 31]. The variable
region TRD and motif IX initiate recognition and bind-
ing of target the DNA sequence. Motifs I-III constitute
the binding site for the methyl group donor AdoMet.
The glutamic acid of the motif VI (ENV) transiently pro-
tonates the endocyclic N3 nitrogen atom of the pyrimi-
dine ring. That facilitates the nucleophylic attack of the
highly conserved cysteine of the motif IV (PCQ) at the
C6 position of the cytosine ring and the subsequent
transfer of the methyl group from AdoMet to the C5
carbon atom. Simultaneously, the glutamate from the
ENV motif stabilizes the flipped base via the contact
with the N4 exocyclic amino group and the glutamine
from TRD (Q237 in M.HhaI) stabilizes the orphan guan-
ine. The general base involved in the proton abstraction
from the transient covalent intermediate is not known.
However, theoretical calculation showed that a hydrox-
ide anion rather than basic residue(s) in the active site
may be involved in the deprotonation step [32].
Figure 1b shows a model of Dnmt3a-CD with short
DNA molecule adopted by superposition of the M.HhaI-
DNA complex structure [20] onto Dnmt3a-CD/Dnmt3L
tetramer structure [16]. The motif IV (PCN instead of
PCQ) contains the catalytic cysteine (C120). The motifs
VI (ENV) contains N167 and motif VIII (QxRxR) con-
tain R200 and R202. In this work, we studied the role of
three conserved residues N167, R200 and R202 in
Dnmt3a in detail as described in the next paragraphs.
R200
The R200 residue in Dnmt3a-CD is one of the highly
conserved amino acids of the motif VIII (QxRxR). It
corresponds to R163 in M.HhaI, R230 in M.SssI, and
R228 in bacterial CpG-specific MTase M.MpeI [33].
There are some indications for a role of this residue
in the cytosine methylation reaction mechanism in-
volving different prokaryotic C5 MTases. First, besides
the glutamic acid of the motif VI (ENV), this arginine
residue could also play critical roles in the proton-
ation of N3 position in the target cytosine. Computer
simulation studies suggested that the function of the
R163 in M.HhaI could be to donate a proton via a
bridging water molecule to N3 of the target cytosine
Fig. 6 Analysis of covalent complex formation of Dnmt3a-CD wt
and its variants with 2-pyrimidinone-substituted DNA duplex
fCG/GP. Fluorograph of a 12.5 % denaturing Laemmli polyacryl-
amide gel. The samples were treated with 1 % SDS for 10 min
at room temperature
Fig. 5 Base flipping induced by Dnmt3a-CD or its variants in complex with Dnmt3L. Emission spectra were recorded for the complex of
Dnmt3a-CD (300 nM) with Dnmt3L (300 nM) and 2-aminopurine containing hemimethylated DNA duplex GBGC/CGMG (200 nM) in the
presence of AdoMet (0.1 mM)
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[34]. Quantum mechanical/molecular mechanics ana-
lysis further indicated that the two arginine residues
R163 and R165 (equivalent to R200 and R202 in
Dnmt3a-CD) in the conserved motif VIII may be es-
sential for stabilizing the delocalized electrons in
cytosine moiety of the transient covalent intermediate
through their intrinsic electrostatic interactions [31, 32]. A
crystal structure of M.MpeI with DNA demonstrated
that residues R228 and R230 (equivalent to R202 in
Dnmt3a-CD) are close to the flipped base (approxi-
mately 3.0 Å) and donate one or two hydrogen bonds
to its O2 [33]. Analysis of the structural model of the
M.SssI•DNA•AdoHcy complex revealed that R230
might be involved in maintaining the proper orienta-
tion of the target cytosine. In M.SssI, alanine substi-
tution of R230 did not affect DNA binding of the
enzyme, whereas its methylation activity was almost
completely abolished, and the efficiency of conjugate
formation of this mutant with 2-pyrimidinone con-
taining DNA was greatly reduced compared to the wt
enzyme [23].
In Dnmt3a, the exchange of R200 to Ala, Glu or
Lys led to a complete loss of methylation activity and
abolished covalent intermediate formation ability. The
target cytosine flipping in the presence of Dnmt3L
was undetectable in the case of R200A and R200E,
while R200K mutant was able to flip out the cytosine,
albeit with only 16 % efficiency compared to the wt-
enzyme. Regarding the substrate binding, the most
appreciable effect was detected when R200 was
substituted for Glu. The product Kd1Kd2 was 5-times
higher than that of the wt-Dnmt3a indicating a weak-
ening of binding. This can be explained by a repul-
sion of a negatively charged carboxyl group of the
glutamic acid side-chain and the phosphate groups of
the DNA backbone. The other R200 substitutions had
no effect (R200A) or slightly improved substrate bind-
ing (R200K). Taken together, the effects of arginine to
alanine substitution in Dnmt3a were more consider-
able than that of M.SssI. The lack of catalytic activity
displayed by the R200A mutant is consistent with the high
degree of conservation of this arginine in C5-MTases [35]
and its extreme importance in target cytosine positioning,
i.e. in both catalysis and cytosine flipping.
R202
The other highly conserved Arg in motif VIII (QxRxR)
is R202 in Dnmt3a-CD. According to the X-ray data, the
side chains of the corresponding R165 (in M.HhaI) [20]
and R228 (in M.MpeI) [33] form a direct hydrogen bond
with the O2 of the target cytosine ring. Homology mod-
eling/molecular dynamic stimulation study predicted the
same hydrogen bonding for the equivalent R162 of
M.HgiDII [36]. It was theoretically proposed that this
Arg residue should stabilize the intermediate with
delocalized electrons in the cytosine ring by forming
a salt-bridge with O2 [37]. Functional and structural
studies of the R165A mutant of M.HhaI showed that
this Arg is important for base flipping, as well as for
positioning the cytosine for the nucleophilic attack by
the conserved C81 [25].
The R202A mutant of the murine Dnmt3a-CD showed
wt level of DNA binding affinity and a very low catalytic
activity [24]. Similarly, in M.HhaI, an Ala replacement of
R165 led to a fourfold increase in DNA binding affinity
and a 105-fold decrease in catalytic rate [25]. The loss of
2AP fluorescence for the complex of R202A with 2AP
containing DNA (Fig. 5 and Table 2) and the lack of the
transient covalent intermediate (Fig. 6) were observed.
These effects are similar to R232A of M.SssI, where
there were no significant changes in DNA binding, but
strong reduction in methylation rate and intensity of 2-
aminopurine fluorescence were observed [23], suggest-
ing that R202 plays a similar role in catalysis in Dnmt3a
as R232 in M.SssI and R165 in M.HhaI. This Arg residue
could participate in positioning of the flipped target base
and creating and stabilization a reactive enamine func-
tionality that could attack the methyl group of AdoMet.
N167
In M.HhaI, motif IV and VI are connected by a highly
conserved H-bond between N120 (ENV) and the car-
bonyl group of P80 (PCQ) that contributes to the posi-
tioning of the two catalytic motifs with respect to each
other. Mutational analysis of the corresponding aspara-
gine residue (N167) in Dnmt3a was performed in [24] to
test for the function of this contact. It was shown that
N167A mutant retains normal AdoMet and DNA bind-
ing, but a 10-fold decrease in methylation rate was ob-
served. It was concluded that alterations at any residue
in motif VI interfere with the accurate positioning of the
glutamate residue, which is directly involved in catalysis.
Fluorescent spectroscopy assays revealed that the
Dnmt3a N167A mutant retains an ability to flip target
cytosine out of DNA with 32 % efficiency compared to
the wt-enzyme (Fig. 5 and Table 2). A detectable quan-
tity of covalent adducts with 2-pirimidinone-containing
DNA was observed (Fig. 6). Since the effects were not so
strong comparing to R200 and R202 substitutions, we
conclude that N167 might contribute to the positioning
of residues from motif VI, but does not play a direct role
in catalysis.
Conclusion
In summary, our data demonstrate the key role of two
highly conserved arginine residues from the motif VIII,
R200 and R202, in catalysis of the cytosine methylation
by Dnmt3a-CD. They are involved in positioning of the
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flipped target base and together with E166 from motif
VI and C120 from the catalytic loop (motif IV) in
creating and stabilization a reactive transient covalent
intermediate that could attack the methyl group of
AdoMet. This characteristic seems common for the
closely related motif VIII arginines of all bacterial and
mammalian cytosine C5 MTases. The information ob-
tained may be also relevant for the explanation of the
consequences of the multiple mutations in the gene
encoding DNMT3A recently reported in patients with
various haematological malignancies [12].
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